Health and Life Sciences news
New therapy for flu may help in fight against COVID-19
A new therapy for influenza virus infections that may also prove effective against many other pathogenic virus infections, including HIV and COVID-19, has been developed by Purdue University scientists.
Beyond COVID-19: New technologies, treatments could help recovered survivors now facing neurological aftereffects
Globally about 50 million people have been diagnosed with COVID-19, 1.2 million have died from the virus and 36.5 million have recovered, according to the World Health Organization.
Parkinson’s patients use telehealth access for immediate speech improvement during COVID-19 pandemic
SpeechVive Inc. announced Thursday (Nov. 19) it is making its remote calibration software and training available free during the COVID-19 global health crisis. The software and training are available to all speech-language pathologists and their patients, as well as Veterans Affairs medical centers and veterans with Parkinson’s disease.
Biotech company gains major funding to keep developing use of immune system to fight cancer
Umoja Biopharma, a Purdue University-affiliated biotechnology company focused on using a patient’s own immune cells to kill cancerous cells, has secured one of the largest initial rounds of funding ever for a Purdue-affiliated company.
Pearls may provide new information processing options for biomedical, military innovations
Pearls have long been favored as objects of beauty. Now, Purdue University innovators are using the gem to provide potential new opportunities for spectral information processing that can be applied to spectroscopy in biomedical and military applications.
Soccer players’ head injury risk could be reduced with simple adjustments to the ball, study finds
Up to 22% of soccer injuries are concussions that can result from players using their heads to direct the ball during a game.
Targeted therapies developed to reduce lung fibrosis
A new treatment option for lung fibrosis is being developed by Purdue University scientists. Lung fibrosis has been a concern for COVID-19 patients.
